Strain Information | |
---|---|
Image | |
BRC No. | RBRC04395 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6;129-Siglec1<tm1(HBEGF)Mtka> |
Former Common name | CD169-DTR KO |
H-2 Haplotype | |
ES Cell line | R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] |
Background strain | |
Appearance | |
Strain development | Developed by Masato Tanaka, RIKEN Research Center for Allergy and Immunology. R1 ES cells were used. C57BL/6 background. |
Strain description | CD169 (Siglec1) DTR knock-in mice. HB-EGF is expressed from CD169 locus. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6JJcl] |
References | Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M J. Clin. Invest., 117, 2268-2278 (2007). 17657313Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. M Saito, T Iwawaki, C Taya, H Yonekawa, M Noda, Y Inui, E Mekada, Y Kimata, A Tsuru, K Kohno Nat. Biotechnol., 19, 746-750 (2001). 11479567Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Saito M, Iwawaki T, Taya C, Yonekawa H, Noda M, Inui Y, Mekada E, Kimata Y, Tsuru A, Kohno K Nat. Biotechnol., 19, 746-750 (2001). 11479567 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2024/06/10Room:3-2Rack:B 2024/03/11Room:3-2Rack:B 2023/12/11Room:3-2Rack:B 2023/09/11Room:3-2Rack:B 2023/06/13Room:3-2Rack:B 2023/03/13Room:3-2Rack:B 2022/12/12Room:3-2Rack:B |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
HBEGF | heparin-binding EGF-like growth factor (human) | 2 | HBEGF | ||||
Siglec1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 2 | Siglec1 | targeted mutation 1, Masato Tanaka | |||
loxP | phage P1 loxP | 2 | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 1 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Human HB-EGF(DTR) cDNA, Phage P1 loxP site, Mouse Siglec1 genomic DNA |
Research application | Cre/loxP system Immunology and Inflammation Research |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Nat. Biotechnol., 19, 746-750 (2001). J. Clin Invest., 117, 2268-2278 (2007).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR/DEVELOPER (Masato Tanaka, Ph.D. and Kenji Kohno, Ph.D.) is requested. |
Depositor | Masato Tanaka (RIKEN) |
Strain Status | Live mice Frozen embryos Frozen sperm |
Strain Availability | Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) Live mouse (3 to 6 months) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Dec 2012 |
BRC mice in Publications |
---|
Chalot M, Barroca V, Devanand S, Hoffschir F, Romeo PH, Moreno SG. Deleterious effect of bone marrow-resident macrophages on hematopoietic stem cells in response to total body irradiation. Blood Adv 6(6) 1766-1779(2022) 35100346 |
Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, Carpenet C, Chou J, Di Gioia M, McGrath ME, Dillen CA, Barrett NA, Lacanfora L, Franco ME, Marongiu L, Iwakura Y, Pucci F, Kruppa MD, Ma Z, Lowman DW, Ensley HE, Nanishi E, Saito Y, O'Meara TR, Seo HS, Dhe-Paganon S, Dowling DJ, Frieman M, Elledge SJ, Levy O, Irvine DJ, Ploegh HL, Williams DL, Zanoni I. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell 185(4) 614-629.e21(2022) 35148840 |
Casella V, Domenjo-Vila E, Esteve-Codina A, Pedragosa M, Cebollada Rica P, Vidal E, de la Rubia I, López-Rodríguez C, Bocharov G, Argilaguet J, Meyerhans A. Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation. Cell Death Dis 14(12) 838(2023) 38110339 |
Oh DS, Oh JE, Jung HE, Lee HK. Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection. Front Immunol 8 819(2017) 28751894 |
Wang D, Li Q, Yang Y, Hao S, Han X, Song J, Yin Y, Li X, Tanaka M, Qiu CH. Macrophage Subset Expressing CD169 in Peritoneal Cavity-Regulated Mucosal Inflammation Together with Lower Levels of CCL22. Inflammation 40(4) 1191-1203(2017) 28466432 |
Jing W, Guo X, Wang G, Bi Y, Han L, Zhu Q, Qiu C, Tanaka M, Zhao Y. Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages. Int Immunopharmacol 78 106012(2020) 31865052 |
Jing W, Qin F, Guo X, Sun Y, Yan C, Qiu C, Tanaka M, Shi B, Zhao Y. G-CSF mediates lung injury in mice with adenine-induced acute kidney injury. Int Immunopharmacol 63 1-8(2018) 30056257 |
Zhang J, Supakorndej T, Krambs JR, Rao M, Abou-Ezzi G, Ye RY, Li S, Trinkaus K, Link DC. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest 129(7) 2920-2931(2019) 31039135 |
Kim HJ, Park JH, Kim HC, Kim CW, Kang I, Lee HK. Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma. Nat Commun 13(1) 6211(2022) 36266311 |
Pirgova G, Chauveau A, MacLean AJ, Cyster JG, Arnon TI. Marginal zone SIGN-R1+ macrophages are essential for the maturation of germinal center B cells in the spleen. Proc Natl Acad Sci U S A 117(22) 12295-12305(2020) 32424104 |